Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | RET | P07949 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | KDR | P35968 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.59 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.59 |
| ▸ | AR | P10275 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL744133 | 0.84 | KDM4E (0.60) | LMNATP53RETTSHRALOX12 | |
| SCHEMBL6719113 | 0.80 | MAOA (0.61) | LMNATP53RETTSHRALOX12 | |
| SCHEMBL1180659 | 0.80 | KDM4E (0.62) | LMNATP53RETTSHRALOX12 | |
| SCHEMBL15676117 | 0.78 | NMUR2 (0.68) | LMNATP53RETTSHRALOX12 | |
| Xanthone SCHEMBL11245548 | 0.77 | MAOA (0.86) | LMNATP53KDM4ECYP3A4MEN1 | |
| SCHEMBL8802227 | 0.77 | KDM4E (0.59) | LMNATP53RETTSHRALOX12 | |
| SCHEMBL10824491 | 0.77 | DDR2 (0.59) | LMNARETHTTKDM4ECYP3A4 | |
| SCHEMBL13978680 | 0.77 | MAOA (0.57) | LMNATP53RETTSHRALOX12 | |
| SCHEMBL28032733 | 0.77 | CYP2C9 (0.57) | LMNATP53RETTSHRALOX12 | |
| SCHEMBL28301960 | 0.77 | CYP3A4 (0.59) | LMNATP53RETTSHRALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1978997-A1 | TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS | Apollo Life Sciences Limited (AU) | 2008-10-15 | — | — | EP | claimed |
| US-20070243132-A1 | Transdermal delivery of pharmaceutical agents | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-10-18 | — | — | US | claimed |
| WO-2007070983-A1 | TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-06-28 | — | — | WO | claimed |
| WO-2019195430-A1 | STREPTOCOCCUS MUTANS GLUCOSYL TRANSFERASE INHIBITORS FOR DENTAL CARIES THERAPY | UAB RESEARCH FOUNDATION (US) | 2019-10-10 | — | — | WO | disclosed |
| US-9828407-B2 | Water soluble and activable phenolic derivatives with dermocosmetic and therapeutic applications and process for preparing said derivatives | LIBRAGEN (FR) | 2017-11-28 | — | — | US | disclosed |
| WO-2008154705-A1 | TRANSDERMAL DELIVERY OF ACTIVE AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2008-12-24 | — | — | WO | disclosed |
| EP-1978997-A1 | TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS | Apollo Life Sciences Limited (AU) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007131286-A1 | NANOSTRUCTURES SUITABLE FOR DELIVERY OF AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-11-22 | — | — | WO | disclosed |
| US-20070243132-A1 | Transdermal delivery of pharmaceutical agents | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-10-18 | — | — | US | disclosed |
| WO-2007070983-A1 | TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-06-28 | — | — | WO | disclosed |
| EP-1124814-B1 | AROMATIC DERIVATIVES AND IRON COMPLEXES THEREOF FOR THE USE AS NORMALISING AGENTS OF THE IRON LEVEL | MEDIDOM LAB (CH) | 2002-12-18 | — | — | EP | disclosed |
| US-6455578-B1 | IRON CHELATING AGENTS FOR TREATMENT OF IRON OVERLOAD AND ANEMIA. | LABORATOIRE MEDIDOM S.A. (CH) | 2002-09-24 | — | — | US | disclosed |
| EP-1124814-A1 | AROMATIC DERIVATIVES AND IRON COMPLEXES THEREOF FOR THE USE AS NORMALISING AGENTS OF THE IRON LEVEL | LABORATOIRE MEDIDOM S.A. (CH) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000026205-A1 | AROMATIC DERIVATIVES AND IRON COMPLEXES THEREOF FOR THE USE AS NORMALISING AGENTS OF THE IRON LEVEL | LABORATOIRE MEDIDOM S.A. (CH) | 2000-05-11 | — | — | WO | disclosed |